Corcept Therapeutics Inc
CORT· Nasdaq
Released Jul 29, 2021, after the close
10-Q filed Jul 29, 2021, 29 days after period end · 0001628280-21-014900
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $91.59M | $88.57M | $72.26M | $62.31M |
| Net Income | $26.52M | $28.33M | $20.19M | $18.20M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.21 |
| $0.23 |
| $0.17 |
| $0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.